Long-term follow-up of 415 patients with chronic lymphocytic leukaemia treated with fludarabine and cyclophosphamide-based chemoimmunotherapy in the frontline ADMIRE and ARCTIC trials, a comprehensive assessment of prognostic factors
Published in: | American Journal of Hematology |
---|---|
Main Authors: | , , , , , , , , , , , , , , , |
Other Authors: | |
Format: | Other/Unknown Material |
Language: | English |
Published: |
2022
|
Subjects: | |
Online Access: | http://hdl.handle.net/10541/625070 https://doi.org/10.1002/ajh.26483 |
id |
ftchristienhs:oai:christie.openrepository.com:10541/625070 |
---|---|
record_format |
openpolar |
spelling |
ftchristienhs:oai:christie.openrepository.com:10541/625070 2023-05-15T14:27:12+02:00 Long-term follow-up of 415 patients with chronic lymphocytic leukaemia treated with fludarabine and cyclophosphamide-based chemoimmunotherapy in the frontline ADMIRE and ARCTIC trials, a comprehensive assessment of prognostic factors Allsup, D. Craig, Z. Cairns, D. Howard, D. Hockaday, A. Bloor, A. Soe, Z. Pepper, C. Gattei, V. Zucchetto, A. Robbe, P. Clifford, R. Schuh, A. Munir, T. Rawstron, A. Hillmen, P. Centre for Atherothrombosis and Metabolic Disease, Hull York Medical School, Hull, UK. Clinical Trials Research Unit, University of Leeds, Leeds, UK. The Christie NHS Foundation Trust, Manchester, UK. St James Institute of Oncology, Leeds, UK. Clinical and Experimental Medicine, Brighton and Sussex Medical School, Brighton, UK. Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano (PN), Italy. Laboratory for Transcriptome Technology, RIKEN Centre for Integrative Medical Sciences, Yokohama, Japan. Department of Haematology, University Hospital Limerick, Limerick, Ireland. Department of Oncology, University of Oxford, Oxford, UK. Haematological Malignancy Diagnostic Service, St James Hospital, Leeds, UK. Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK. 2022 http://hdl.handle.net/10541/625070 https://doi.org/10.1002/ajh.26483 en eng https://dx.doi.org/10.1002/ajh.26483 Allsup DJ, Craig Z, Cairns D, Howard D, Hockaday A, Bloor A, et al. Long‐term follow‐up of 415 patients with chronic lymphocytic leukemia treated with fludarabine and cyclophosphamide‐based chemoimmunotherapy in the frontline ADMIRE and ARCTIC trials: A comprehensive assessment of prognostic factors. American Journal of Hematology. Wiley; 2022. 35108412 doi:10.1002/ajh.26483 http://hdl.handle.net/10541/625070 American Journal of Hematology Other 2022 ftchristienhs https://doi.org/10.1002/ajh.26483 2022-04-21T22:23:36Z Other/Unknown Material Arctic Arctic The Christie School of Oncology: Christie Research Publications Repository Arctic American Journal of Hematology 97 5 |
institution |
Open Polar |
collection |
The Christie School of Oncology: Christie Research Publications Repository |
op_collection_id |
ftchristienhs |
language |
English |
author2 |
Centre for Atherothrombosis and Metabolic Disease, Hull York Medical School, Hull, UK. Clinical Trials Research Unit, University of Leeds, Leeds, UK. The Christie NHS Foundation Trust, Manchester, UK. St James Institute of Oncology, Leeds, UK. Clinical and Experimental Medicine, Brighton and Sussex Medical School, Brighton, UK. Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano (PN), Italy. Laboratory for Transcriptome Technology, RIKEN Centre for Integrative Medical Sciences, Yokohama, Japan. Department of Haematology, University Hospital Limerick, Limerick, Ireland. Department of Oncology, University of Oxford, Oxford, UK. Haematological Malignancy Diagnostic Service, St James Hospital, Leeds, UK. Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK. |
format |
Other/Unknown Material |
author |
Allsup, D. Craig, Z. Cairns, D. Howard, D. Hockaday, A. Bloor, A. Soe, Z. Pepper, C. Gattei, V. Zucchetto, A. Robbe, P. Clifford, R. Schuh, A. Munir, T. Rawstron, A. Hillmen, P. |
spellingShingle |
Allsup, D. Craig, Z. Cairns, D. Howard, D. Hockaday, A. Bloor, A. Soe, Z. Pepper, C. Gattei, V. Zucchetto, A. Robbe, P. Clifford, R. Schuh, A. Munir, T. Rawstron, A. Hillmen, P. Long-term follow-up of 415 patients with chronic lymphocytic leukaemia treated with fludarabine and cyclophosphamide-based chemoimmunotherapy in the frontline ADMIRE and ARCTIC trials, a comprehensive assessment of prognostic factors |
author_facet |
Allsup, D. Craig, Z. Cairns, D. Howard, D. Hockaday, A. Bloor, A. Soe, Z. Pepper, C. Gattei, V. Zucchetto, A. Robbe, P. Clifford, R. Schuh, A. Munir, T. Rawstron, A. Hillmen, P. |
author_sort |
Allsup, D. |
title |
Long-term follow-up of 415 patients with chronic lymphocytic leukaemia treated with fludarabine and cyclophosphamide-based chemoimmunotherapy in the frontline ADMIRE and ARCTIC trials, a comprehensive assessment of prognostic factors |
title_short |
Long-term follow-up of 415 patients with chronic lymphocytic leukaemia treated with fludarabine and cyclophosphamide-based chemoimmunotherapy in the frontline ADMIRE and ARCTIC trials, a comprehensive assessment of prognostic factors |
title_full |
Long-term follow-up of 415 patients with chronic lymphocytic leukaemia treated with fludarabine and cyclophosphamide-based chemoimmunotherapy in the frontline ADMIRE and ARCTIC trials, a comprehensive assessment of prognostic factors |
title_fullStr |
Long-term follow-up of 415 patients with chronic lymphocytic leukaemia treated with fludarabine and cyclophosphamide-based chemoimmunotherapy in the frontline ADMIRE and ARCTIC trials, a comprehensive assessment of prognostic factors |
title_full_unstemmed |
Long-term follow-up of 415 patients with chronic lymphocytic leukaemia treated with fludarabine and cyclophosphamide-based chemoimmunotherapy in the frontline ADMIRE and ARCTIC trials, a comprehensive assessment of prognostic factors |
title_sort |
long-term follow-up of 415 patients with chronic lymphocytic leukaemia treated with fludarabine and cyclophosphamide-based chemoimmunotherapy in the frontline admire and arctic trials, a comprehensive assessment of prognostic factors |
publishDate |
2022 |
url |
http://hdl.handle.net/10541/625070 https://doi.org/10.1002/ajh.26483 |
geographic |
Arctic |
geographic_facet |
Arctic |
genre |
Arctic Arctic |
genre_facet |
Arctic Arctic |
op_relation |
https://dx.doi.org/10.1002/ajh.26483 Allsup DJ, Craig Z, Cairns D, Howard D, Hockaday A, Bloor A, et al. Long‐term follow‐up of 415 patients with chronic lymphocytic leukemia treated with fludarabine and cyclophosphamide‐based chemoimmunotherapy in the frontline ADMIRE and ARCTIC trials: A comprehensive assessment of prognostic factors. American Journal of Hematology. Wiley; 2022. 35108412 doi:10.1002/ajh.26483 http://hdl.handle.net/10541/625070 American Journal of Hematology |
op_doi |
https://doi.org/10.1002/ajh.26483 |
container_title |
American Journal of Hematology |
container_volume |
97 |
container_issue |
5 |
_version_ |
1766300827727691776 |